EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 2

Ensembl ID : ENSDARG00000007739
Gene Symbol: ATP1A1A.2
6 Enzyme and pathways 5 Cross references
296 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 3

Ensembl ID : ENSDARG00000039131
Gene Symbol: ATP1A1A.3
6 Enzyme and pathways 5 Cross references
297 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 4

Ensembl ID : ENSDARG00000001870
Gene Symbol: ATP1A1A.4
6 Enzyme and pathways 5 Cross references
299 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 5

Ensembl ID : ENSDARG00000040252
Gene Symbol: ATP1A1A.5
6 Enzyme and pathways 5 Cross references
297 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1b

Ensembl ID : ENSDARG00000019856
Gene Symbol: ATP1A1B
6 Enzyme and pathways 5 Cross references
255 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSDARG00000010472
Gene Symbol: ATP1A2A
6 Enzyme and pathways 5 Cross references
206 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1a

Ensembl ID : ENSDARG00000013144
Gene Symbol: ATP1B1A
5 Cross references
152 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1b

Ensembl ID : ENSDARG00000076833
Gene Symbol: ATP1B1B
9 Enzyme and pathways 4 Cross references
265 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2a

Ensembl ID : ENSDARG00000099203
Gene Symbol: ATP1B2A
5 Cross references
195 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSDARG00000034424
Gene Symbol: ATP1B2B
9 Enzyme and pathways 5 Cross references
197 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3a

Ensembl ID : ENSDARG00000015790
Gene Symbol: ATP1B3A
9 Enzyme and pathways 5 Cross references
229 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3b

Ensembl ID : ENSDARG00000042837
Gene Symbol: ATP1B3B
5 Cross references
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).